ES2124342T3 - Uso de cadenas ramificadas de aminoacidos para la fabricacion de un medicamento para tratar la discinesia tardia. - Google Patents

Uso de cadenas ramificadas de aminoacidos para la fabricacion de un medicamento para tratar la discinesia tardia.

Info

Publication number
ES2124342T3
ES2124342T3 ES94111220T ES94111220T ES2124342T3 ES 2124342 T3 ES2124342 T3 ES 2124342T3 ES 94111220 T ES94111220 T ES 94111220T ES 94111220 T ES94111220 T ES 94111220T ES 2124342 T3 ES2124342 T3 ES 2124342T3
Authority
ES
Spain
Prior art keywords
manufacture
amino acids
medicinal product
branched chains
late dyskinesia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94111220T
Other languages
English (en)
Inventor
Mary Ann Richardson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York State Office of Mental Health
Original Assignee
New York State Office of Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York State Office of Mental Health filed Critical New York State Office of Mental Health
Application granted granted Critical
Publication of ES2124342T3 publication Critical patent/ES2124342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN METODO PARA DISMINUIR O ATENUAR LOS SINTOMAS DE ENFERMEDADES DE MOVIMIENTO QUE PUEDEN SER SECUNDARIAS PARA EL TRATAMIENTO DE ENFERMEDADES PSIQUIATRICAS CON DROGAS ANTIPSICOTICAS PRINCIPALMENTE NEUROLEPTICAS, O ENFERMEDADES NEUROLOGICAS PRIMARIAS. ESTE TRATAMIENTO IMPLICA LA ADMINISTRACION DE UNA COMIDA ENRIQUECIDA CON ACIDOS DE AMINO NEUTRAL GRANDES O UN SUPLEMENTO DIETARIO DE ACIDOS DE AMINO NEUTRAL GRANDES PARA PACIENTES QUE SUFREN DE ESTAS ENFERMEDADES.
ES94111220T 1993-07-21 1994-07-19 Uso de cadenas ramificadas de aminoacidos para la fabricacion de un medicamento para tratar la discinesia tardia. Expired - Lifetime ES2124342T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/093,955 US5393784A (en) 1993-07-21 1993-07-21 Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof

Publications (1)

Publication Number Publication Date
ES2124342T3 true ES2124342T3 (es) 1999-02-01

Family

ID=22241901

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94111220T Expired - Lifetime ES2124342T3 (es) 1993-07-21 1994-07-19 Uso de cadenas ramificadas de aminoacidos para la fabricacion de un medicamento para tratar la discinesia tardia.

Country Status (7)

Country Link
US (1) US5393784A (es)
EP (1) EP0642791B1 (es)
AT (1) ATE171620T1 (es)
CA (1) CA2128486C (es)
DE (1) DE69413637T2 (es)
DK (1) DK0642791T3 (es)
ES (1) ES2124342T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670539A (en) * 1993-07-21 1997-09-23 New York State Office Of Mental Health Treatment of movement disorders using large neutral amino acids
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5789443A (en) * 1997-04-25 1998-08-04 Gollobin; Charlotte Method for treating flushing associated with menopause
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
US6200758B1 (en) 1999-02-19 2001-03-13 New York State Office Of Mental Health Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders
US6245812B1 (en) 1999-07-15 2001-06-12 Charlotte Gollobin Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
AU2001266853B2 (en) * 2000-06-14 2005-02-17 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
US20060094785A1 (en) * 2002-07-12 2006-05-04 Guttuso Jr Thomas J Use of amino acids for treatment of various conditions
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129652A (en) * 1976-08-16 1978-12-12 Nelson Research & Development Company Method for potentiating neuroleptic drugs
US4138484A (en) * 1976-08-16 1979-02-06 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
US4209531A (en) * 1978-09-13 1980-06-24 Children's Hospital Medical Center Method for treating phenylketonuria
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
US5028622A (en) * 1988-05-06 1991-07-02 Ajinomoto Company, Inc. Administration of amino acids as treatment for neurodegenerative disorders
US5206218A (en) * 1989-04-03 1993-04-27 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Also Published As

Publication number Publication date
EP0642791B1 (en) 1998-09-30
EP0642791A1 (en) 1995-03-15
US5393784A (en) 1995-02-28
CA2128486C (en) 2007-04-17
DE69413637T2 (de) 1999-05-27
CA2128486A1 (en) 1995-01-22
DE69413637D1 (de) 1998-11-05
ATE171620T1 (de) 1998-10-15
DK0642791T3 (da) 1999-06-21

Similar Documents

Publication Publication Date Title
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
DE69918977D1 (de) Aminosäure-stabilisierte gabapentin und pregabalin zubereitungen und verfahren zu ihrer herstellung
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
HUS1300046I1 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére alkalmas gyógyszer elõállítására
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
DE69508192D1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
PT90246A (pt) Processo para a preparacao de inibidores da protease do hiv, nomeadamente amidas de aminoacidos, uteis para o tratamento da sida
EP0684040A3 (en) Skin treatment composition
ES2124342T3 (es) Uso de cadenas ramificadas de aminoacidos para la fabricacion de un medicamento para tratar la discinesia tardia.
EP0725083A4 (en) LOW MOLECULAR, ACETYLATED HYALURONIC ACID, EMOLLIENT, AND PROCESSES FOR OBTAINING AND PURIFYING THIS ACID
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
CA2294607A1 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
AU4300497A (en) Process for the manufacture of aliphatic alpha, omega amino nitriles
DK213484A (da) Farmaceutisk middel til behandling af slagtilfaelde og lignende krampesygdomme
MX9602836A (es) MEZCLA QUE CONTIENE UNO O VARIOS ALFA-AMINOACIDOS Y SUS DERIVADOS, O AMBOS, Y UNO O VARIOS CICLOPENTANO- beta-AMINOACIDOS Y SUS DERIVADOS, O AMBOS.
DE69418260D1 (de) Verfahren zur Herstellung von L-3,4-Dihydroxyphenylalanin
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
DE3561201D1 (en) Medicaments containing tripeptides
DE69310552D1 (de) Hochdruckpumsystem und dessen betriebsverfahren
BR9911969A (pt) Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
ES2166545T3 (es) Procedimiento de preparacion de un aminoacido activado.
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 642791

Country of ref document: ES